Anthem Biosciences Ltd Share Price

Q: What is the share price of Anthem Biosciences Ltd today?

Anthem Biosciences Ltd share price as on 12 Jun 2026 is ₹783.7

Pharmaceuticals

NSE: ANTHEM Mid Cap ISIN: INE0CZ201020

As on 13 June 2026 at 02:40 IST

₹783.70

+ 3.65

(0.47%)

Sell Buy

Over 1 Month

-0.53%

Over 6 Months

13.53%

Over 1 Year

6.80%

Over 3 Years

None%

Anthem Biosciences Ltd Summary

Close ₹780.05

Open ₹760

High ₹787

Low ₹756.80

Volume 3,43,422

Net Turnover (in Cr) ₹26.77

52Wk High ₹873.50

52Wk Low ₹579.15

52Wk High / Low

579.15

873.50

Anthem Biosciences Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹43,932.03

EPS (TTM) 12.22

Book Value (BV) 56.55

Div. Yield -

P/E (TTM) 65.48

Price/Book Value 13.79

Delivery % 43.62 %

Face Value 2

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA 19.41

ROE 22.98

Debt-Equity 0.06

Net Profit Margin 27.50

Operating Profit Margin 43.39

Anthem Biosciences Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,930.29	1,483.07	1,133.99	1,280.24	1,140.45
Total Expenses	1,273.42	1,005.75	698.50	734.10	774.88
Profit Before Tax	656.87	477.32	497.30	546.14	365.57
Profit After Tax	451.26	367.31	385.19	405.54	271.29
Operating Profit After Depreciation	667.20	486.85	442.26	556.23	382.53

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	705.10	482.52	448.89	329.01	361.41
Total Non Current Assets	1,070.87	916.56	691.29	521.15	418.02
Total Current Assets	1,736.72	1,481.56	1,323.17	1,097.71	615.80
Total Assets	2,807.58	2,398.11	2,014.46	1,618.87	1,033.83
Total Shareholder's Fund	2,409.86	1,924.65	1,740.67	1,355	701.46

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	418.34	140.15	305.99	332.91	277.64
Net Cash Used In Investing Activities	-152.11	-221.46	-376.02	-205.45	-196.03
Net Cash Used In Financing Activities	-133.60	-77.18	63.97	180.68	-63.27

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,950.09	1,488.06	1,134.30	1,280.24	1,140.45
Total Expenses	1,238.67	1,003.29	698.32	733.64	774.87
Profit Before Tax	711.42	484.77	497.78	546.59	365.58
Profit After Tax	506.19	374.78	385.67	405.99	271.31
Operating Profit After Depreciation	720.51	493.92	442.73	556.68	382.55

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	624.06	477.69	448.89	329.01	361.41
Total Non Current Assets	1,171.49	878.74	673.39	522.10	417.93
Total Current Assets	1,664.07	1,445.49	1,319.62	1,097.08	615.81
Total Assets	2,835.56	2,324.23	1,993.02	1,619.18	1,033.73
Total Shareholder's Fund	2,473.21	1,933.07	1,741.62	1,355.46	701.47

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	439.84	164.41	318.98	333.35	277.55
Net Cash Used In Investing Activities	-246.31	-191.76	-377.91	-205.78	-196.09
Net Cash Used In Financing Activities	-66.42	-131.59	52.85	180.68	-63.27

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	610.94	423.15	550.03	540.21	483.20
Total Expenses	343.73	265.96	332.12	348.71	288.01
Profit Before Tax	277.91	130.47	229.61	186.25	178.31
Profit After Tax	189.76	92.82	173.43	135.79	82.62
Operating Profit after Depreciation	318.42	190.72	266.14	214.31	209.25

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	582.50	416.58	552.23	538.01	478.98
Total Expenses	315.51	253.53	326.57	342.58	280.87
Profit Before Tax	300.73	150.11	253.31	198.94	212.84
Profit After Tax	211.67	112.12	198.43	148.34	122.56
Operating Profit after Depreciation	327.62	202.97	279.46	223.16	235.93

Anthem Biosciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 762.23

S2 744.42

S3 732.03

Pivot 774.62

R1 792.43

R2 804.82

R3 822.63

Moving Average

20 SMA 771.27

50 SMA 750.25

100 SMA 699.33

200 SMA 714.09

Anthem Biosciences Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Anthem Biosciences Ltd Top Mutal Funds Invested

Fund Name	AUM
Quant Mid Cap Fund	4.49%
SBI Healthcare Opportunities Fund	3%
SBI MNC Fund	2.76%
HDFC Manufacturing Fund	1.10%
SBI Midcap Fund	1.05%

Anthem Biosciences Ltd News

Anthem Biosciences schedules AGM

On 22 July 2026

20 May 2026, 06:29 pm

Board of Anthem Biosciences recommends final dividend

Of Rs 2 per share

20 May 2026, 12:13 pm

Anthem Biosciences to hold board meeting

On 19 May 2026

13 May 2026, 11:01 am

Anthem Biosciences allots 1.03 lakh equity shares under ESOP

05 Feb 2026, 07:12 pm

Anthem Biosciences to announce Quarterly Result

On 5 February 2026

28 Jan 2026, 10:55 am

Anthem Biosciences Ltd Stock Analysis

Annual revenue for Anthem Biosciences Ltd increased by 31.05% to ₹1,950.09 crore in FY 2025 from ₹1,488.06 crore in FY 2024.
Annual Net Profit for Anthem Biosciences Ltd increased by 35.06% to ₹506.19 crore in FY 2025 from ₹374.78 crore in FY 2024.
Promoter Shareholding in Anthem Biosciences Ltd decreased by 0.02% in the most recent quarter, from 74.69% in December 2025 to 74.68% in March 2026.
Anthem Biosciences Ltd delivered a 1-year return of 6.80% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Anthem Biosciences Ltd share price moved up by 0.47% from its previous close of INR ₹780.05. The latest Anthem Biosciences Ltd share price is INR ₹783.70.
Anthem Biosciences Ltd share price today has been at a low of 778.25 and a high of 787.95. Over the past 52 weeks, the Anthem Biosciences Ltd share price has seen a low of 579.15 and a high of 873.50.